Sake rarrabuwa don samfuran da ƙananan allurai na CBD

ƙofar Ƙungiyar Inc.

cbd samfurin

Medsafe ta sake rarraba samfurin maganin cannabis na magani cannabidiol (CBD) daga maganin sayan magani zuwa takamaiman magani (masu harhada magunguna kawai) a cikin New Zealand. Ostiraliya ta yi irin wannan sauyi a cikin 2020.

Ko da yake a halin yanzu babu CBDAn yarda da samfuran a New Zealand, don haka wannan na iya canzawa a nan gaba. Duk wani samfurin da aka amince da shi nan gaba za a iya ba da shi ta hanyar masana harhada magunguna masu rijista ga marasa lafiya sama da shekaru 18. A halin yanzu babu samfura da ake samu a wannan rukunin. Gabaɗaya, waɗannan samfuran ne waɗanda za a yi amfani da su don magance ƙananan cututtuka.

Magungunan CBD

Har ila yau, masana'antar ta nuna a baya cewa canji a cikin rarrabuwa na iya ba da ƙarin dama don bincike kan ingancin asibiti da amincin CBD. Wannan na iya haifar da ƙarin dama don amincewa da magungunan da ke ɗauke da cannabidiol.

Har zuwa yanzu, babbar hanyar samar da cannabidiol ta kasance azaman samfurin cannabis na magani wanda Medsafe ba ta yarda da shi ba amma ya cika mafi ƙarancin ƙa'idodin ƙa'idodin Drugs of Misuse (Medical Cannabis). Wannan yana nufin ana iya samun dama ta hanyar takardar sayan magani daga likita mai rijista.

Source: nzdoctor.co.uk (En)

Shafuka masu dangantaka

Bar sharhi

[banner = "89"]